GDTC – cytomed therapeutics limited - ordinary shares (US:NASDAQ)
Stock Stats
News
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
Form S-8 CytoMed Therapeutics
Form 6-K CytoMed Therapeutics For: Jan 06
Form 6-K CytoMed Therapeutics For: Dec 05
Form 6-K CytoMed Therapeutics For: Nov 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.